US STOCKS-Wall St rebounds; biotech shares snap losing streak
* Biotech shares rise, rebounding after recent losses
* Consumer confidence hits six-year high in March
* Options on momentum stocks suggest more bullish bets
* Dow up 0.6 pct; S&P 500 up 0.4 pct; Nasdaq up 0.2 pct (Updates to close)
By Angela Moon
NEW YORK, March 25 (Reuters) - U.S. stocks ended higher on Tuesday, rebounding from a two-day decline as the hard-hit biotechnology sector regained its momentum and a strong read on consumer confidence increased optimism about the economy.
Trading was choppy throughout the day with the Nasdaq at one point turning lower, led by a sharp reversal in biotech shares.
.So-called momentum stocks were still down for the day but off their lows, including Netflix, down 2.1 percent at $370.84. Netflix has declined for 14 of the past 15 sessions, falling almost 19 percent over that stretch
Biotech shares also reversed earlier losses, including Regeneron Pharma, ending 0.8 percent higher at $308.87, and Gilead Sciences Inc, up 1.3 percent at $73.03. Continuación...